Saturday, 5 September 2026European Markets
Via News Knowledge File

BlackRock, Inc.

organization80% conf.·synced Sep 5, 2026

Investment management firm

60
sourced metrics
700
relationships
20
stated objectives
1
Via News reports

Every fact below is drawn from Via News's knowledge graph and linked to the source document it came from. Nothing here is unsourced. How we source →

Key metrics · each point sourced

Price 52 Week Low
922.90USD
Sep 4, 2026reference only
Market Cap
173872103674USD
Sep 4, 2026reference only
Stock Return Ytd
3.4%
Sep 4, 2026reference only
Stock Price
1122.29USD
Sep 4, 2026reference only
Price 52 Week High
1202.59USD
Sep 4, 2026reference only
Total Assets
175875000000.0USD
Jun 30, 2026reference only
Eps
12.19USD_per_share
Jun 30, 2026reference only
Stockholders Equity
57613000000.0USD
Jun 30, 2026reference only
Cash
10492000000.0USD
Jun 30, 2026reference only
Shares Outstanding
154996807.0shares
Jun 30, 2026reference only
Revenue
7084000000.0USD
Jun 30, 2026reference only
Total Liabilities
111335000000.0USD
Jun 30, 2026reference only
Net Income
1914000000.0USD
Jun 30, 2026reference only
Operating Income
2461000000.0USD
Jun 30, 2026reference only
Capex
106000000.0USD
Mar 31, 2026reference only
Operating Cash Flow
-980000000.0USD
Mar 31, 2026reference only

Stated objectives

Maintain adjusted operating margin of 45% or greater

source
target: 45% or greater stated

Grow private markets to insurance, private markets to wealth, digital assets, and active ETFs each to $500 million in annual revenue

source
target: $500 million per initiative by 2030-01-01 00:00:00stated

Target $400 billion in gross private markets fundraising through 2030

source
target: 400 billion USD by 2030-01-01 00:00:00stated

Target mid-single-digit percentage increase in G&A and broadly flat headcount in 2026 after annualizing HPS and Preqin impacts

source
target: mid-single-digit % G&A increase; flat headcount by 2026-12-31 00:00:00stated

Deploy capital for roughly 20 late-stage insurance client conversations to build diversified portfolios across public and private markets, with deployments expected to pull through second half of 2026

source
target: 20 late-stage insurance conversations by 2026-12-31 00:00:00stated

Target $1.8 billion in share repurchases during 2026

source
target: 1.8 billion USD by 2026-12-31 00:00:00stated

Recommends Bitcoin allocation of 1-2% in multi-asset portfolios

source
target: 1-2% stated

See retail as a vast untapped pool of capital for private markets

source
stated

BlackRock requires $3 billion in XRP ETF demand threshold before filing XRP ETF application

source
target: 3000000000 stated

Generate $500 million in annual revenue from crypto business

source
target: 500000000 by 2031-01-01 00:00:00stated

Relationship graph · 700 connections

subsidiary of
203
Developed by
136
Invested in
70
Employs
62
managed by
42
Owns
29
Covered by
29
headquartered in
27

Via News coverage

This Knowledge File is assembled from Via News's source-traceable knowledge graph. Metrics, objectives and relationships are extracted from primary and credible secondary documents and refreshed on a schedule. Read our methodology →
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Capital Surge Meets Investor Caution: Record Funding Rounds and Government Contracts Amid Valuation Skepticism
A single-week cluster of large AI/fintech funding rounds (Socure, Stability AI, Emerald AI, Generalist AI, Instinct, Gatik, Regent Craft) shows venture capital still pouring into AI infrastructure, identity, and autonomy plays, while Palantir's Army TITAN contract win coincided with a 6% stock drop — signaling that even flagship AI-defense revenue isn't immune to market reassessment of AI valuations. Efficiency-focused innovations like Multiverse Computing's model compression suggest the sector is also pivoting toward cost/inference economics as capital intensity draws scrutiny.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Morgan Stanley & Co. LLC
The same metric (eps) for the same entity (Morgan Stanley & Co. LLC) reported for the identical fiscal period (Q1 2026) and observation date (2026-03-31) has two conflicting values: 3.43 USD_per_share vs 3.08 USD. This is not a temporal change — both observations claim to measure the same point in time. The ~10% discrepancy (0.35 USD difference) is material for a financial metric.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,981
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,981 facts checked against source5,273 source documents archived
Query this data → isubstrate.com